Reply to "Subcutaneous terbutaline as an alternative to aerosolized albuterol"

J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2450-2452. doi: 10.1016/j.jaip.2020.04.016. Epub 2020 Apr 22.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.
  • Comment

MeSH terms

  • Albuterol
  • COVID-19*
  • Humans
  • Hypersensitivity*
  • Pandemics
  • SARS-CoV-2
  • Terbutaline

Substances

  • Terbutaline
  • Albuterol